
Aves & Aps Medi Research Private Limited
About Aves & Aps Medi Research Private Limited
Data last updated:
Aves & Aps Medi Research Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the healthcare services segment of the healthcare sector. It was incorporated on 06 July 2012.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U85110DL2012PTC238500.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Seema Rawal and Sudhir Rawal.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at C – 78 Farmers Society Sector – 13 Rohini, Delhi, India – 110085.
Company details
Contact details
Aves & Aps Medi Research Private Limited's registered office is in Delhi, Delhi.
- Registered AddressC – 78 Farmers Society Sector – 13 Rohini, Delhi, India – 110085
- IndustryHealthcare, Human Health Activities, Specialized Hospitals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aves & Aps Medi Research Private Limited
FY 2016 filings availableFinancial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Aves & Aps Medi Research Private Limited, buy the company report.
Board of directors of Aves & Aps Medi Research Private Limited
Aves & Aps Medi Research has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seema Rawal | Director | 06 Jul 2012 | 14 Years 4 Months | As last reported |
| Sudhir Rawal Also directs: Sudhir Srivastava Innovations Private Limited | Director | 06 Jul 2012 | 14 Years 4 Months | As last reported |
Legal cases
No court or tribunal cases involving Aves & Aps Medi Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aves & Aps Medi Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aves & Aps Medi Research Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aves & Aps Medi Research Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Seema Rawal was appointed as Director on 06 Jul 2012.
Frequently asked questions
Aves & Aps Medi Research has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Aves & Aps Medi Research was a private limited company based in Delhi, India. The company worked in human health activities, within the healthcare industry. It was incorporated on 06 July 2012 and is registered under CIN U85110DL2012PTC238500. The company has been struck off by the Registrar of Companies and is no longer operational.
Aves & Aps Medi Research had 2 directors:
- Seema Rawal - Director
- Sudhir Rawal - Director
The CIN (Corporate Identification Number) of Aves & Aps Medi Research is U85110DL2012PTC238500. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Aves & Aps Medi Research is at C – 78 Farmers Society Sector – 13 Rohini, Delhi, India – 110085.
Aves & Aps Medi Research was incorporated on 06 July 2012. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Aves & Aps Medi Research on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from 2015 are in the company report.
Aves & Aps Medi Research operated in the healthcare industry, in the human health activities segment. It worked in this industry before it was struck off.
Seema Rawal was appointed as Director on 06 Jul 2012. Sudhir Rawal was appointed as Director on 06 Jul 2012.
The compliance status of Aves & Aps Medi Research is active non-compliant as of 26 August 2026.

